Marksans Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE750C01026
  • NSEID: MARKSANS
  • BSEID: 524404
INR
309.10
1.2 (0.39%)
BSENSE

Oct 09

BSE+NSE Vol: 12.1 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryMarksans Pharma VS Pharmaceuticals & Biotechnology
 
1D
0.39%
1.23%
1W
-4.95%
0.78%
1M
-6.46%
-3.07%
YTD
71.58%
-14.96%
1Y
82.52%
-11.8%
3Y
192.16%
10.62%
5Y
335.35%
20.67%
10Y
472.41%
158.27%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.29%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.65%
0.33%
11.98%
6 Months
76.58%
0.51%
77.09%
1 Year
82.52%
0.50%
83.02%
2 Years
4.07%
0.62%
4.69%
3 Years
192.16%
2.27%
194.43%
4 Years
554.18%
5.67%
559.85%
5 Years
335.35%
4.54%
339.89%

Latest dividend: 0.9029572836801752 per share ex-dividend date: Aug-20-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Marksans Pharma Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-4.46%
2
Quartile
quartile-2
Jun-Sep
17.49%
1
Quartile
quartile-1
Mar-Jun
74.83%
1
Quartile
quartile-1
YTD
82.11%
4
Quartile
quartile-4
2025
-39.19%
1
Quartile
quartile-1
2024
84.18%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Marksans Pharma Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-4.46%
2
Quartile
quartile-2
Jun-Sep
17.49%
1
Quartile
quartile-1
Mar-Jun
74.83%
1
Quartile
quartile-1
YTD
82.11%
4
Quartile
quartile-4
2025
-39.19%
1
Quartile
quartile-1
2024
84.18%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Marksans Pharma Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-4.46%
1
Quartile
quartile-1
Jun-Sep
17.49%
1
Quartile
quartile-1
Mar-Jun
74.83%
1
Quartile
quartile-1
YTD
82.11%
4
Quartile
quartile-4
2025
-39.19%
1
Quartile
quartile-1
2024
84.18%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available